1716973,16227086,10750375,9695185,9143697,22070056,21178327,21956693,20829376,20181615,19594633,21756229,8475064,7782275,1691828,1985119,8496602[uid] - Search Results

Year	Number of Results
1990	1
1991	2
1993	2
1995	1
1997	1
1998	1
2000	1
2005	1
2009	1
2010	3
2011	4
2012	1
2024	0

1

CD22 antigen: biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion.

Schwartz-Albiez R, Dörken B, Monner DA, Moldenhauer G. Schwartz-Albiez R, et al. Int Immunol. 1991 Jul;3(7):623-33. doi: 10.1093/intimm/3.7.623. Int Immunol. 1991. PMID: 1716973

2

CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.

Tedder TF, Poe JC, Haas KM. Tedder TF, et al. Adv Immunol. 2005;88:1-50. doi: 10.1016/S0065-2776(05)88001-0. Adv Immunol. 2005. PMID: 16227086 Review.

3

CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity.

Tedder TF, Sato S, Poe JC, Fujimoto M. Tedder TF, et al. Keio J Med. 2000 Mar;49(1):1-13. doi: 10.2302/kjm.49.1. Keio J Med. 2000. PMID: 10750375 Free article.

4

CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.

Sato S, Tuscano JM, Inaoki M, Tedder TF. Sato S, et al. Semin Immunol. 1998 Aug;10(4):287-97. doi: 10.1006/smim.1998.0121. Semin Immunol. 1998. PMID: 9695185 Review.

5

CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.

Tedder TF, Tuscano J, Sato S, Kehrl JH. Tedder TF, et al. Annu Rev Immunol. 1997;15:481-504. doi: 10.1146/annurev.immunol.15.1.481. Annu Rev Immunol. 1997. PMID: 9143697 Review.

6

CD22 as a target for cancer therapy.

Tu X, LaVallee T, Lechleider R. Tu X, et al. J Exp Ther Oncol. 2011;9(3):241-8. J Exp Ther Oncol. 2011. PMID: 22070056 Review.

7

CD22 regulates adaptive and innate immune responses of B cells.

Kawasaki N, Rademacher C, Paulson JC. Kawasaki N, et al. J Innate Immun. 2011;3(4):411-9. doi: 10.1159/000322375. Epub 2010 Dec 17. J Innate Immun. 2011. PMID: 21178327 Free PMC article.

8

CD22 serves as a receptor for soluble IgM.

Adachi T, Harumiya S, Takematsu H, Kozutsumi Y, Wabl M, Fujimoto M, Tedder TF. Adachi T, et al. Eur J Immunol. 2012 Jan;42(1):241-7. doi: 10.1002/eji.201141899. Epub 2011 Nov 10. Eur J Immunol. 2012. PMID: 21956693 Free article.

9

Sialic acid-IVIg targeting CD22.

Blank M, Shoenfeld Y. Blank M, et al. Blood. 2010 Sep 9;116(10):1630-2. doi: 10.1182/blood-2010-06-289892. Blood. 2010. PMID: 20829376 Free article. No abstract available.

10

In vivo targeting of B-cell lymphoma with glycan ligands of CD22.

Chen WC, Completo GC, Sigal DS, Crocker PR, Saven A, Paulson JC. Chen WC, et al. Blood. 2010 Jun 10;115(23):4778-86. doi: 10.1182/blood-2009-12-257386. Epub 2010 Feb 24. Blood. 2010. PMID: 20181615 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year